Nachrichten zur Hims & Hers Health Aktie

HIMS Q3 Earnings Call Highlights Marketing Reset and Margin Pressure

Hims & Hers shifts focus on weight-loss expansion and international growth as Q3 margin pressure, subscriber losses and reduced profit…

HIMS Q3 Earnings Call Highlights Marketing Reset and Margin Pressure

Hims & Hers Health, Inc. HIMS is prioritizing a broader weight-loss offering and international expansion over immediate subscriber gains following…

Why Is Hims & Hers Health (HIMS) Bringing Andrew Huberman Onto Its Board?

Hims & Hers Health (NYSE:HIMS) has appointed neuroscientist Dr. Andrew Huberman to its Board of Directors. Dr. Huberman will also…

Why Is Hims & Hers Health Stock Falling Today? - Hims & Hers Health (NYSE:HIMS)

Hims & Hers stock dropped after a Q3 loss and guidance cut, but Needham reaffirmed its Buy rating, seeing the…

Hims & Hers Drops 18% as Q3 Loss and Profit Outlook Cut Disappoint; Novo Nordisk Slides 2%, Eli Lilly Holds Steady

A surprise quarterly loss and a weaker profit outlook are hitting Hims & Hers (NYSE:HIMS) hard. Hims & Hers stock…

Hims & Hers Drops 18% as Q3 Loss and Profit Outlook Cut Disappoint; Novo Nordisk Slides 2%, Eli Lilly Holds Steady

Revenue jumped nearly 49%, yet Hims & Hers investors fled anyway. Behind the selloff sit shrinking margins, a subscriber slip,…

Why Hims & Hers Health (HIMS) shares are getting obliterated today

What happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 18.5% in the afternoon session after the company…

Why Hims & Hers Health (HIMS) shares are getting obliterated today

What happened? Shares of telehealth company Hims & Hers Health NYSE:HIMS fell 18.5% in the afternoon session after the company…

Hims & Hers to offer an unapproved peptide after US eases curbs

(Corrects lede and headline to show that Hims new offering is for one unapproved peptide, not some) By Amina Niasse…

Why Is Hims & Hers Health (HIMS) Adding Dr. Andrew Huberman To Its Board?

Hims & Hers Health (NYSE:HIMS) appointed neuroscientist Dr. Andrew Huberman to its Board of Directors.Dr. Huberman will also serve as…

Hims & Hers Health stock is trading at $18.555

Hims & Hers Health stock has a bearish daily structure, and the hourly chart confirms that bias. Oversold readings complicate…

Hims & Hers earnings analysis: questions answered and next catalysts

Hims & Hers earnings analysis: questions answered and next catalysts…

Hims & Hers Health Inc (HIMS) (Q3 2026) Earnings Call Highlights: Revenue Surges 49% to ...

Hims & Hers Health Inc (HIMS) posts its second straight quarter of accelerating growth, but subscriber declines and margin pressure…

Five US states join FTC lawsuit alleging Hims & Hers engaged in unlawful privacy practices

By Kanishka Singh WASHINGTON, Nov 10 (Reuters) - Five US states have joined the Federal Trade Commission in a lawsuit…

Five US states join FTC suit over alleged Hims & Hers unlawful practices

WASHINGTON, Nov 10 (Reuters) - Five US states have joined the Federal Trade Commission in a lawsuit that alleges telehealth…

HIMS May See Heightened ‘Gyrations’ As Weight-Loss Drug Trends Fuel Subscriber Uncertainty, Jefferies Warns

Jefferies said a ‘dynamic GLP-1 environment’ would continue to cause volatility in Hims & Hers’ subscriptions…

Hims & Hers Health slides 14% after earnings miss, guidance cut

Hims & Hers shares fall 14% after Q3 revenue of $890.3 million and EPS of -$0.14 miss estimates; 2026 revenue…

Hims & Hers stock sinks after Q3 results, outlook disappoints

Hims & Hers Health stock plunged after the company gave a weaker-than-expected Q4 revenue forecast.…

Hims & Hers cuts 2026 earnings outlook despite 49% revenue growth

Hims & Hers Health (NYSE:HIMS), the US telehealth company, reduced its full-year adjusted earnings forecast despite reporting 49% revenue growth…

What Hims & Hers Health (HIMS) Said on Its Q3 Earnings Call

Hims & Hers Health (NYSE:HIMS) reported third-quarter revenue growth of 49% but lost 100,000 subscribers from the prior quarter, as…

Hims & Hers revenue jumps 49% to $890 million as it cuts its 2026 profit outlook

Hims & Hers Q3 2026 revenue rose 49% to $890.4 million, with international revenue up 321% to $233.3 million. Gross…

Hims & Hers to offer unapproved peptides after US eases curbs

Nov 9 - Hims & Hers Health said on Monday it will begin offering some unapproved peptide treatments in November…

Earnings call transcript: Hims & Hers misses Q3 2026 profit view, shares fall

Earnings call transcript: Hims & Hers misses Q3 2026 profit view, shares fall…

Hims & Hers Health, Inc. (HIMS) Misses Q3 EPS by 20c, Offers Guidance

Hims & Hers Health, Inc. (NYSE: HIMS) reported Q3 EPS of ($0.14), $0.20 worse than the analyst estimate of $0.06.…

Hims & Hers Health Q3 2026 Earnings Call Transcript - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health (NYSE:HIMS) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has…

Hims & Hers Health declines following double miss, lowered guidance

Hims & Hers stock fell after Q3 misses and lower 2026 guidance despite strong revenue growth. Read more here.…

Hims & Hers Health (HIMS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Hims & Hers Health (HIMS) give a sense of how its business performed in…

Hims & Hers Health (HIMS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Hims & Hers Health (HIMS) give a sense of how its business performed in…

Hims & Hers Health Posts $33 Million Loss After Sales Miss Estimates

The digital healthcare company narrowed its full-year revenue outlook after third-quarter sales came in lower than expected.…

Hims & Hers Non-US Revenue Grows 4x to $233M; Total $890M

95,000+ executives read Business Engineer for the AI strategy frameworks cited by ChatGPT, Claude, and Perplexity. A note on sourcing.…

Hims & Hers Cuts Profit Guide After Loss

Hims & Hers reported third-quarter revenue of $890.4m and a loss, then cut its full-year profit guide. Its shares had…

Hims & Hers Has Fewer Subscribers Than 3 Months Ago

Hims & Hers (HIMS) earnings show subscribers down to 2.79 million from 2.89 million in June, as revenue rose 49%…

Hims & Hers cuts 2026 profit forecast as margins contract

Hims & Hers Health cut its full-year core profit forecast on Monday as higher costs tied to branded weight-loss drugs…

Hims & Hers cuts 2026 profit forecast as margins contract

Nov 9 (Reuters) - Hims & Hers Health cut its full-year core profit forecast on Monday as higher costs tied…

Hims & Hers cuts 2026 profit forecast as margins contract

Hims & Hers Health NYSE:HIMS cut its full-year core profit forecast on Monday as higher costs tied to branded weight-loss…

Hims & Hers earnings missed by $0.20, revenue fell short of estimates

Hims & Hers earnings missed by $0.20, revenue fell short of estimates…

Hims & Hers Stock Slips Further as Q3 Print Disappoints - Hims & Hers Health (NYSE:HIMS)

Heres a detailed look inside the Q3 earnings report from Hims & Hers Health.…

Hims & Hers Health, Inc. (HIMS) Q3 Earnings and Revenues Miss Estimates

Hims & Hers Health (HIMS) delivered earnings and revenue surprises of -57.14% and -0.34%, respectively, for the quarter ended September…

Hims & Hers Health, Inc. (HIMS) Q3 Earnings and Revenues Miss Estimates

Hims & Hers Health (HIMS) delivered earnings and revenue surprises of -57.14% and -0.34%, respectively, for the quarter ended September…

Hims & Hers Health (NYSE:HIMS) posts Q3 2026 sales in line with estimates but full-year sales guidance misses expectations

Telehealth company Hims & Hers Health NYSE:HIMS met Wall Street’s revenue expectations in Q3 2026, with revenue up 48.6% year…

Hims & Hers Health (NYSE:HIMS) posts Q3 2026 sales in line with estimates but full-year sales guidance misses expectations

Telehealth company Hims & Hers Health (NYSE:HIMS) met Wall Street’s revenue expectations in Q3 2026, with revenue up 48.6% year…

dpa-AFX ProFeed